Abstract Alpha-synuclein is the main component of Lewy bodies, a histopathological finding of Parkinson's disease. Prolyl oligopeptidase (PREP) is a serine protease that binds to α-synuclein and accelerates its aggregation in vitro. PREP enzyme inhibitors have been shown to block the α-synuclein aggregation process in vitro and in cellular models, and also to enhance the clearance of α-synuclein aggregates in transgenic mouse models. Moreover, PREP inhibitors have induced alterations in dopamine and metabolite levels, and dopamine transporter immunoreactivity in the nigrostriatal tissue. In this study, we characterized the role of PREP in the nigrostriatal dopaminergic and GABAergic systems of wild-type C57Bl/6 and PREP knockout mice, and the effects of PREP overexpression on these systems. Extracellular concentrations of dopamine and protein levels of phosphorylated dopamine transporter were increased and dopamine reuptake was decreased in the striatum of PREP knockout mice, suggesting increased internalization of dopamine transporter from the presynaptic membrane. Furthermore, PREP overexpression increased the level of dopamine transporters in the nigrostriatal tissue but decreased phosphorylated dopamine transporters in the striatum in wild-type mice. Our results suggest that PREP regulates the function of dopamine transporter, possibly by controlling the phosphorylation and transport of dopamine transporter into the striatum or synaptic membrane.
Introduction
Prolyl oligopeptidase (PREP) is a highly conserved serine protease that hydrolyses proline-containing peptides shorter than 30 amino acids at least in vitro and also has nonhydrolytic functions [1, 2] . In vitro, PREP cleaves many peptide hormones such as substance P, thyrotropin-releasing hormone, arginine-vasopressin, bradykinin, and neurotensin [1] . Many of these neuropeptides are related to Parkinson's disease (PD), Alzheimer's disease (AD), and other neurodegenerative diseases, and alterations in the PREP enzyme activity has been observed in the brain tissue of PD, AD, Lewy body dementia, and Huntington's disease patients [3] . However, the role of PREP in neuropeptide cleavage in vivo, and the physiological importance of PREP remained unclear [4] [5] [6] .
PREP is widely distributed in different tissues in mammalian body but the highest activity has been measured in the brain. PREP localizes in GABAergic and cholinergic interneurons of the thalamus and cortex, as well as in the GABAergic neurons of the nigrostriatal tract and also, in lesser extent, in dopaminergic (DAergic) neurons [7] [8] [9] . PREP is mainly found in the cell cytosol but it can also be localized in the nucleus and bound to the membranes [1, 10] . Moreover, PREP has been shown to co-localize with α-synuclein (aSyn), which is the main component of the Lewy bodies of PD, and tau aggregates and beta-amyloid plaques of AD in the post mortem brain samples [11] . Earlier, it has been shown that PREP directly binds to aSyn and accelerates its aggregation in cellular models [12, 13] . A potent and specific PREP inhibitor, KYP-2047, was able block the aggregation of aSyn and enhance the clearance of aSyn aggregates in both aSyn overexpressing cell lines and in aSyn transgenic mice [12] . KYP-2047 also increased the concentrations of dopamine (DA) and its metabolites and decreased DA transporter (DAT) immunoreactivity in the striatal tissue in wild-type mice and in aSyn transgenic mice, suggesting that PREP might have a role in regulating the nigrostriatal DAergic system [14] . Moreover, in the study by Jalkanen et al. [15] , two PREP inhibitors, KYP-2047 and JTP-4819, decreased extracellular DA levels in the rat striatum. Otherwise, the role of PREP in the nigrostriatal neurotransmitter systems has not been extensively studied.
Although the concentration of extracellular DA is predominantly regulated by diffusion, the kinetics and the volume of extrasynaptic DA is mainly regulated by DAT [16] . DAT function is regulated with several different mechanisms but the main regulator of internalization of DAT is protein kinase C (PKC) mediated phosphorylation [17] [18] [19] . Changes in DAT function has been connected to PD and other DA-related diseases, and altered levels of DAT markers have been found in the brain of PD patients [20] . Balance in DAT levels in synaptic cleft is crucial, since increased DAT on cellular membrane can lead to the accelerated DA uptake, which in turn leads to oxidative stress, terminal damage, and DA-induced cellular apoptosis [21, 22] . aSyn binds to DAT and regulates its localization and function by recruiting and stabilizing the transporter on plasma membrane [22] [23] [24] . aSyn aggregation, the key player in cellular toxicity in PD, may cause elevated striatal extracellular levels of DA observed in the aSyn overexpressing mice [25] . Furthermore, aSyn aggregation has effect on DA packing and DAT trafficking [26, 27] . However, this has been mostly studied in vitro, whereas mechanisms in vivo are poorly understood although they might be pivotal in the pathophysiology of PD and other neurodegenerative diseases [28] . Previous findings indicate that the regulation of DAergic system, DAT function, and aSyn aggregation by modulating PREP functions might be a potential drug target in synucleinopathies and in other neurodegenerative diseases [14] . However, the physiological role of PREP protein in the nigrostriatal GABAergic and DAergic systems is still unclear, and needs to be clarified to further support development of the PREP inhibitors as drug therapy for PD. In this study, we have characterized the role of PREP in the nigrostriatal DAergic and GABAergic systems and its effect on DAT function by using PREP inhibitors, PREP knockout mice, and local PREP overexpression. Our results revealed that PREP regulates the DA level and uptake by affecting DAT trafficking in DAergic cells.
Materials and Methods

Reagents
The reagents were purchased from Sigma-Aldrich (MO, USA) if not otherwise specified. Ethanol was purchased from Altia (Finland). The PREP inhibitor, KYP-2047 (4-phenylbutanoyl-l-prolyl-2(S)-cyanopyrrolidine), was synthesized in the School of Pharmacy, University of Eastern Finland, as previously described by Jarho et al. [29] . KYP-2047 has been extensively characterized and the pharmacological and pharmacokinetic profile indicates that it is highly selective, potent, and crosses the blood-brain barrier both in rats and mice [12, 14, 15, [30] [31] [32] . Adeno-associated virus vectors (AAVs), AAV1-EF1α-hPREP (AAV-PREP), and AAV1-EF1α-eGFP (AAV-GFP), were obtained from the National Institute of Drug Abuse (Dr. Brandon Harvey, Intramural Research Program, Baltimore MD, USA). Plasmid construction was performed as described by Savolainen et al. [14] .
Animals
Male C57BL/6J mice (Wt) (7-9 weeks old; Envigo, The Netherlands) and PREP gene knockout mice (PREP-KO) (Deltagene Inc, CA, USA) in C57BL/6JRccHsd genetic background (5-10 back crossings) were used in this study [33, 34] . Deletion of exon 3 of the PREP gene was done as described by Di Daniel et al. [34] . Mice were housed under standard laboratory conditions (12-h light/dark cycle; room temperature 23 ± 2°C; relative humidity = 50 ± 15 %) in individually ventilated cages (Mouse IVC Green Line, Techniplast, Italy) with bedding (Aspen chips, 5 × 5 × 1 mm, 4HP, Tapvei, Estonia); nesting material (Aspen strips, PM90L, Tapvei); and aspen brick (100 × 20 × 20 mm, Tapvei). Mice had access to chow food (Teklad 2016, Envigo, UK) and filtered and irradiated water ad libitum. After surgical procedures, animals were individually housed for the durations of the experiment. The experiments were carried out according to the European Communities Council Directive 86/609/EEC and were approved by the Finnish National Animal Experiment Board.
Surgical Procedures
Mice were anesthetized with isoflurane (4 % induction, 1.5-2.0 % maintenance; Attane vet 1000 mg/g, Piramal Healthcare, UK) and the recombinant AAV1 viral vectors were injected above the substantia nigra (SN) in a stereotaxic operation. To target the SN, viral vectors were given as a single injection (volume 1 μL, rate 0.2 μL/min) into the left hemisphere, 3.1 mm anterior and 1.2 mm lateral to bregma, and 4.2 mm below the dura (stereotaxic coordinates according to Paxinos and Frankin [35] ). Buprenorphine (0.1 mg/kg s.c.;
Temgesic 0.3 mg/mL, Reckitt Benckiser Healthcare, UK) was given before the operation, 12 and 24 h after the surgery to relieve post-operative pain. Guide cannula for microdialysis was inserted into the left striatum at 0.6 mm anterior and 1.8 mm lateral, and 2.7 mm below the dura. The cannula was fastened to the skull with dental cement (Aqualox, Voco, Germany) and two stainless steel screws (1.2 × 3 mm, DIN84, Helsingin Ruuvihankinta, Finland).
Characterization of Viral Vectors
To characterize the distribution and function of viral vectors, AAV1-EF1α-eGFP or AAV1-EF1α-hPREP were injected unilaterally above the SN to Wt mice and the expression and distribution was examined by immunohistochemistry 2 and 4 weeks post-injection. PREP enzyme activity in the striatal tissue was measured 4 weeks post-injection. Detailed description of PREP enzyme activity assay and immunohistochemistry can be found in the Supplementary material (Fig. S1, 2 ).
Conventional Microdialysis
Microdialysis was performed 5 weeks after the viral vector injections as described earlier [36] . A microdialysis probe (1-mm cuprophan membrane, o.d. 0.2 mm, 6 kDa cut-off; AT4.9.1. Cu, AgnTho's, Sweden) was inserted into the guide cannula 2 h before the experiment and the probe was perfused with a modified Ringer solution (147 mM NaCl, 1.2 mM CaCl 2 , 2.7 mM KCl, 1.0 mM MgCl 2 , and 0.04 mM ascorbic acid) at the flow rate of 2.0 μL/min. Five baseline samples were collected (20 min/40 μL/sample) after the stabilization period. After the collection of baseline samples, the probe was perfused 2 × 20 min with 10 and 30 μM damphetaminesulphate with 2 × 20 min recovery time between the concentrations. The mice were euthanized right after the microdialysis experiment by cervical dislocation followed by decapitation. The brains were removed and rapidly frozen in isopentane on dry ice. The concentrations of dopamine (DA), its metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) as well as gamma-aminobutyric acid (GABA) in dialysates were measured using slightly modified versions of the HPLC methods that have been described earlier [37, 36] . Detailed description of the HPLC systems can be found in the Supplementary material.
Similar microdialysis experiment was performed with PREP inhibitor administration in Wt mice. After collecting baseline samples for 4 × 20 min, KYP-2047 or vehicle was injected intraperitoneally and, thereafter, 15 × 20 min samples were collected. A repeated experiment was carried out with the same mice after a 5-day treatment of KYP-2047 or vehicle. In the repeated experiment, 9 × 20 min samples were collected after the stabilization period. Amphetamine-induced DA release was measured in another set of mice. The mice received an injection of KYP-2047 or vehicle after the collection of 4 × 20 min baseline samples and administration of amphetamine via probe (as described above) was started 3 × 20 min after the injection.
No-Net-Flux Microdialysis
No-net-flux microdialysis was performed with PREP-KO mice and Wt littermates. A microdialysis probe (1-mm cuprophan membrane, o.d. 0.2 mm, 6 kDa cutoff; AT4.9.1. Cu, AgnTho's, Sweden) was inserted into the guide cannula 2 h before the experiment and the probe was perfused with a modified Ringer solution (147 mM NaCl, 1.2 mM CaCl 2 , 2.7 mM KCl, 1.0 mM MgCl 2 , and 0.04 mM ascorbic acid) at the flow rate of 0.6 μL/min. Four concentrations of DA in Ringer solution (C in ; 0, 2, 10, and 20 nM) were perfused through the probes in a random order, and 3 × 30 min samples were collected at each C in for HPLC analysis.
Linear equation was constructed for each animal by plotting the net flux of DA through the probe (DA in − DA out ) against DA in , where DA out is the dialysate DA concentration acquired during the perfusion and DA in is the DA concentration of the perfusion fluid. Based on this equation, the extracellular DA level (DA ext ) and the in vivo extraction fraction (E d ) was calculated as described by Parsons and Justice [38] . The DA ext value stands for the perfusion fluid DA concentration at which there is no-net-flux of DA through the probe (DA in − DA out = 0). E d , on the other hand, has been shown to describe combined DAT, NET, and uptake 2 functions [39] [40] [41] [42] .
Tissue HPLC Analysis
Striatal tissue samples were punched below the corpus callosum +0.74 mm from the bregma to 2 mm depth by using sample corer (i.d. of 2 mm) with a plunger (Stoelting Co., USA) on a cryostat (Leica CM3050) and the samples from the SN were punched from a brain slice (thickness 1-1.5 mm) −2.8 mm from the bregma by using sample corer (i.d. of 1 mm) with a plunger (Stoelting Co.). Tissue processing and HPLC analysis of the concentrations of DA, its metabolites DOPAC and HVA, and 5-HIAA in the tissue were performed as described earlier [43] . Detailed description of the HPLC equipment can be found in the Supplementary material. The tissue concentrations of GABA and glutamate were analyzed with HPLC equipped with a fluorescence detector. Detailed description of the HPLC system can be found in the Supplementary material. Concentrations are calculated as nanograms per milligram of brain tissue.
Western Blotting
Frozen tissue was homogenized with an ultrasound sonicator (GM35-400, Rinco Ultrasonic, Switzerland) in five volumes of ice-cold modified RIPA buffer (50 mM Tris HCl pH 7.4, 1 % NP-40, 0.25 % sodium deoxycholate, 150 mM NaCl) containing Halt Phosphatase Inhibitor (Product# 87786, Thermo Fisher Scientific, IL, USA) and Halt Protease Inhibitor cocktail (Product# 78430, Thermo Fisher Scientific). After centrifuging at 16,000g and 4°C for 15 min, the supernatants were collected. Protein concentration was measured by the BCA method (Thermo Fisher Scientific). For SDS-PAGE, 30 μg of protein was loaded onto a 4-20 % Mini-PROTEAN TGX precast gel (Product # 4561094, Bio-Rad, CA, USA). Gel was transferred to nitrocellulose membrane (Trans-blot Turbo, Product# 1704158, Bio-Rad) by using Trans-blot Turbo Transfer System (BioRad). The membranes were blocked by 5 % skim milk. Western blots for DAT, tyrosine hydroxylase (TH), and betaactin were done with SNAP i.d. 2.0 protein detection system (Merck Millipore, MA, USA), except phospho (T53)-DAT that was done by incubating the membrane with primary antibody overnight at +4°C and thereafter with secondary antibody for 2 h at room temperature. Following primary antibodies and dilutions were used: DAT, rabbit anti-DAT (#PA1-4656, Thermo Fisher Scientific, dilution 1:1000 in 0.5 % skim milk in 0.1 % Tween-20 in Tris-buffered saline (TTBS)); phospho (T53)-DAT (pDAT), rabbit anti-pDAT (#ab183486, AbCam, UK, dilution 1:500 in 5 % skim milk in 0.05 % TTBS); TH, rabbit anti-TH (#ab153, Merck Millipore, dilution 1:2000 in 0.5 % skim milk in 0.1 % TTBS); beta-actin, rabbit anti-beta-actin (#4967S, Signaling Technology, MA, USA, dilution 1:1000 in 0.5 % skim milk in 0.1 % TTBS). Goat anti-rabbit HRP was used for secondary antibody for all the primary antibodies (#31460, Thermo Fisher Scientific, dilution 1:2000 in 0.5 % skim milk in 0.1 % TTBS). The images were captured with LI-COR C-digit chemiluminescence scanner (LI-COR, Germany). Three independent WB experiments were performed.
Optical density (OD) values of the WB images were analyzed using ImageJ software (NIH, MD, USA). The OD values were normalized to the loading control (beta-actin) ODs.
Fast-Scan Cyclic Voltammetry
Dopamine release was evoked on acute striatal slices of male mice (5-6 months of age) with electrical stimulations and measured with a carbon fiber electrode calibrated with known dopamine concentrations. The signal was amplified with Axopatch 200B amplifier (Molecular Devices LLC, CA, USA), digitized (ITC-18 board; Instru-Tech, NY, USA) and analyzed with a computer routine in IGOR Pro (WaveMetrics, OR, USA) as earlier described [44] . Detailed description of fast-scan cyclic voltammetry can be found in the Supplementary material.
PREP Inhibitor Treatments
Wt mice received either the PREP inhibitor KYP-2047 (5 mg/ kg) or vehicle twice a day intraperitoneally (i.p.) for 5 days. KYP-2047 was diluted in 0.5 % dimethylsulfoxide (DMSO) in saline. Vehicle treatment groups received 0.5 % DMSO in saline.
Cylinder Test
Cylinder test (cylinder height 15 cm, diameter 12 cm) was used to measure motor asymmetry in spontaneous forelimb use after the unilateral microinjections [45, 46] . Baseline paw preference scores were acquired before the stereotaxic surgery, 2 and 4 weeks post-injection. In brief, mouse was filmed for 5 min. If the number of the individual rearing episodes that resulted in the mouse touching cylinder wall was less than 10, the mouse was excluded from further analysis. Data was analyzed by a formula
Contralateralþ0:5ÂBoth
IpsilateralþContralateralþBoth Â 100; where BBoth^paws were defined as touches where animal landed both of the forepaws simultaneously on the cylinder wall after the rearing. A noninjected control mouse should score around 50 % in this test. The animals were not allowed to habituate to the testing cylinder before the video recording. The baseline level was set to 100 %; the results at 2 and 4 weeks were calculated as percentage of the baseline.
Locomotor Activity Test
The spontaneous locomotor activity of the AAV-transfected animals was measured before the AAV injections and 4 weeks after the injections and that of the PREP inhibitor-treated animals was measured before the treatment and after a 5-day treatment with KYP-2047. At the beginning of the lights-on period, the animals were placed in transparent cages (25 cm × 25 cm × 15 cm, with food pellets and a water burette) with the activity monitor measuring infrared beam interruptions (MED Associates, GA, USA). The measurement was started immediately to record also the explorative behavior in a novel environment, and the data were collected at 15-min intervals for 20 h.
Statistical Analysis
Statistical analysis was performed using either GraphPad Prism (version 6.02, GraphPad Software, Inc., CA, USA) or SPSS Statistics (Version 22.0.0.1 IBM Corporation, NY, USA) software. One-and two-way ANOVA with Bonferroni post test and Student's t test were used as statistical tests. Data is presented as mean ± standard error of the mean (SEM). The results were considered to be statistically significant at p < 0.05.
Results
Increased Dopaminergic Activity in the Striatum of PREP Knockout Mice
The impact of absence of PREP in the nigrostriatal DAergic and GABAergic systems was examined in PREP-KO mice and their Wt littermates by striatal no-net-flux microdialysis to measure the extracellular baseline level of DA, by conventional microdialysis to study the amphetamine-induced DA release, and by tissue HPLC analysis to measure the concentration of neurotransmitters and their metabolites in the striatal and SN tissue. The striatal extracellular DA concentration was significantly increased in PREP-KO mice compared to Wt littermates in no-net-flux microdialysis study ( Fig. 1a ; p = 0.036, Student's t test). The PREP-KO mice had approximately 80 % higher concentration of extracellular DA in the striatum than their Wt littermates. Additionally, the PREP-KO mice showed more pronounced amphetamineinduced release of DA in the conventional microdialysis experiment ( Fig. 2b; 10 μM amphetamine (AMPH), genotype effect: F 1,37 = 6.799, p = 0.013; 30 μM AMPH genotype effect: F 1,37 = 8.681, p = 0.006, repeated measures 2-way ANOVA). PREP-KO mice were also more active during the exploratory phase in the locomotor activity test (Fig. S3a in the Supplementary material, 0-60 min: F 1,22 = 7.567, p = 0.012, repeated measures 2-way ANOVA). Tissue concentrations of DA, 5-HT, their metabolites, glutamate, and GABA in the striatum and SN were similar in both genotypes (Fig. 3) . Fig. 1 The PREP knockout (KO) mice had higher extracellular concentrations of dopamine (DA) in the striatum compared to the wild-type (Wt) littermates in the no-net-flux microdialysis study (a). Fast-scan cyclic voltammetry recordings revealed a delayed DA reuptake in the KO mice. The picture is showing the averaged and normalized single pulse stimulation-evoked DA transients for both genotypes, to illustrate the delayed DA reuptake in the KO mice (b). Heights of DA release peaks were slightly higher in KO mice but the difference was not statistically significant (c). Half width (d) and tau values (e) of DA transients were longer in the KO mice and there was a similar trend in the fall time (f). a n = 5-6, b-f n = 13-14. Bars represent mean ± SEM, *p < 0.05, **p < 0.01, Student's t test
Altered DAT Phosphorylation and Function in the PREP Knockout Mice
The levels of DA-related proteins DAT and TH in the striatal and SN tissue were studied by Western blotting, and DAT function was studied in acute striatal slices by fast-scan cyclic voltammetry. PREP-KO and Wt mice had similar concentration of DAT in the nigrostriatal tract (Fig. 4a, b) but the level of phosphorylated DAT was higher in the striatum of PREP-KO mice ( Fig. 4c ; p = 0.0338, Student's t test). In addition, TH level was increased in the SN tissue but not in the striatal tissue of PREP-KO mice ( Fig. 4e, f ; p = 0.0038, Student's t test). Several parameters representing the DA release and reuptake dynamics were calculated from the single-pulse stimulation-evoked DA transients recorded with fast-scan cyclic voltammetry in acute striatal slices. The efficacy of DA reuptake by DAT can be estimated from the half width of the transients (the width of the transient at half maximum of the DA peak) as well as from the fall time and tau values of the exponential decays of the transients [47] . The half widths (Fig. 1d , p = 0.0020, Student's t test) and values (Fig. 1e , p = 0.028, Student's t test) of DA peaks were increased in the PREP-KO mice and there was a similar trend in the fall time (Fig. 1f , p = 0.078, Student's t test) suggesting that the DA reuptake was delayed. The amount of DA released by single pulses, i.e., the peaks of the transients was slightly higher in PREP-KO mice but there was no statistically significant difference (Fig. 1c, p = 0.356, Student's t test) . The recovery of the DA terminals from the preceding exocytosis in paired-pulse stimulations and the amounts of DA released by burst stimulations were similar in the PREP-KO and Wt mice (Fig. S4a,b in the Supplementary material) . In addition, in slice recordings, in the dorsal striatal area, the amphetamine-induced DAT reversal and DA release through DAT was unchanged (Fig. S4c, d in the Supplementary material). g, n) . Restoring the PREP function to the KO mice increased the striatal DA (a) but did not have an effect on the levels of other neurotransmitters or their metabolites. Wt-GFP n = 18-21, Wt-PREP n = 15-19, KO-GFP n = 7-10, KO-PREP n = 3-7. Bars represent mean ± SEM, *p < 0.05, **p < 0.01, Student's t test. Values were normalized to 100 % (levels in the intact side of the brain)
Overexpression of PREP Elevates the Striatal DAT in Wild-Type Mice
The effect of PREP overexpression in the nigrostriatal tract was studied by the striatal microdialysis and tissue HPLC analysis, and the DA-related proteins DAT and TH were studied by Western blotting. The behavioral effects caused by the unilateral nigral PREP overexpression were studied by cylinder test and locomotor activity test. The nigrostriatal overexpression of PREP by AAV-hPREP did not have an effect on the extracellular baseline concentration of DA (Fig. 2a) and its metabolites (Fig. 2c,d ) or amphetamine-induced release of DA (Fig. 2b) but the baseline level of 5-HIAA ( Fig.2e ; p = 0.0048, Student's t test) and GABA ( Fig. 2f ; p = 0.047, Student's t test) were elevated. Tissue concentrations of DA, 5-HT, their metabolites, glutamate and GABA in the striatum were unchanged (Fig. 3) but DA in the SN was elevated (Fig. 3h) . Overexpression of PREP also increased the protein level of DAT in the striatum ( Fig. 5a ; p = 0.027, Student's t test) and in the SN (Fig. 5b ; p = 0.033, Student's t test) measured by Western blotting. Moreover, phosphorylated DAT was decreased in the striatum ( Fig. 5c ; p = 0.0281, Student's t test) but not in the SN (Fig. 5d) . The amount of TH was unchanged both in the striatum and SN (Fig. 5e-f) . Fig. 4 PREP knockout (KO) and wild-type (Wt) littermates had the same amount of dopamine transporters (DAT) in the striatal (Str) (a) and the nigral (SN) (b) tissue, but the levels of phosphorylated DAT (pDAT) were enhanced in the Str of KO mice (c) measured by Western blotting. Tyrosine hydroxylase (TH) levels were increased in the SN (e) but not in the Str (f) of KO mice. Wt n = 6-8, and KO n = 8 (except pDAT SN n = 3-4) in each group. Bars represent means ± SEM; *p < 0.05, **p < 0.01, Student's t test Supplementary material) but AAV-GFP decreased the use of the contralateral paw in the cylinder test (Fig. S5 in the Supplementary material, baseline vs. 4 weeks, F 2,32 = 3.547, *p = 0.044, one-way ANOVA, Bonferroni post test).
Unilateral PREP overexpression did not have an effect o n t h e l o c o m o t o r a c t i v i t y ( F i g . S 3 b in the
Restoring PREP Protein to the Substantia Nigra of PREP Knockout Mice Increases the Striatal Dopamine PREP function was restored to PREP-KO mice by a nigral injection of AAV-hPREP, and the nigrostriatal DAergic and Fig. 5 The amount of dopamine transporter (DAT), phosphorylated DAT (pDAT), and tyrosine hydroxylase (TH) in the striatal (Str) and the nigral (SN) tissue was measured by Western blotting 5 weeks after a supranigral injection of AAVhPREP or AAV-eGFP. Overexpression of PREP increased DAT levels in the Str (a) and in the SN (b), and decreased pDAT in the Str (c) but not in the SN (d). Amount of TH was not changed in the Str (e) or in the SN (f). DAT and TH: n = 6-9 in each group, pDAT: n = 3-4 in each group. Bars represent mean ± SEM, *p < 0.05, Student's t test GABAergic systems were studied 5 weeks post-injection by conventional microdialysis and tissue HPLC analysis. Behavior was studied with cylinder test and locomotor activity test. Restoring the PREP function to the PREP-KO mice did not have an effect on the extracellular concentration of DA, its metabolites, or 5-HIAA (Fig. 2a, c-f ) but the striatal tissue concentration of DA was increased ( Fig. 3a ; p = 0.016, Student's t test). Levels of DA-related proteins DAT, pDAT, and TH were not changed (Fig. S6 in the Supplementary material) . Use of contralateral paw was increased in the mice that received an AAV-hPREP injection (Fig. S5 in PREP inhibition elevated concentration of DA in the striatum of A30P point-mutated transgenic mice but not in the Wt mice in a previous study [14] . In addition, immunoreactivity of DAT was increased in both Wt and transgenic mice. To study these observations further, we examined the effect of acute and long-term PREP inhibition on the nigrostriatal DAergic and GABAergic system by microdialysis, tissue HPLC analysis and Western blotting. The single dose of PREP inhibitor, KYP-2047, did not have an effect on the extracellular baseline levels of DA, its metabolites, GABA and 5-HIAA ( 
Discussion
In this study, we comprehensively studied the absence, restoration, and overexpression of PREP protein on the nigrostriatal pathway to reveal the role of PREP in the striatal and the nigral DAergic and GABAergic system. In addition, the effect of acute and 5-day PREP inhibitor treatment on the nigrostriatal neurotransmitter systems was studied. The most significant finding was that the absence of PREP protein in the knockout mice caused elevated extracellular DA levels and impaired DAT function in the striatum, suggesting a role for PREP in DAT internalization. To our knowledge, this is the first study where the role of PREP on DAT function has been observed, and the overall importance of PREP protein for neurotransmitter systems of the nigrostriatal pathway has been characterized.
In earlier studies, PREP expression has been detected in the nigrostriatal GABAergic neurons and to some extent in DAergic neurons, and administration of PREP inhibitors has decreased the extracellular DA in the rat striatum [15] , and chronic PREP inhibitor treatment has decreased DAT immunoreactivity in the mouse striatal tissue [14] . However, the physiological role of PREP protein in the nigrostriatal neurotransmission has remained unclear. In this study, we found that the PREP-KO mice had higher concentrations of pDAT in the striatum. This indicates that PREP-KO mice have more internalized DAT and less DAT on the presynaptic membrane as phosphorylation is the main regulator of DAT internalization [17, 19] . As DAT can transport DA only when located on the cellular membrane, low concentrations of DAT on the membrane cause impaired reuptake of DA, which was seen in the current study as higher extracellular concentrations of DA in the no-net-flux microdialysis and as delayed reuptake of DA in the fast-scan cyclic voltammetry measurements. Elevated amphetamine-induced release of DA in the conventional microdialysis experiment also further supports the altered DAT function and DA reuptake in the PREP-KO mice. Amphetamine rapidly diminishes DAT function by phosphorylation of DAT via PKC or oxidative inactivation leading to a massive reduction of DA clearance in the extracellular space [48] . Reduced DAT function on the presynaptic membranes of PREP-KO mouse leads to reduced reuptake and increased extracellular DA that was seen in the microdialysis experiment. The high concentration of TH in the SN can also explain the higher amount of the extracellular DA in the PREP-KO mouse as TH is the rate limiting enzyme in DA synthesis [49] .
Altered DAT function induced by absence or overexpression of PREP suggests that PREP has an important role in the nigrostriatal DAergic system regulating the phosphorylation and internalization of DAT. This was further supported by the overexpression studies, where we detected increased level of DAT in the nigrostriatal tract and reduced pDAT in the striatum, indicating that internalization of DAT is decreased and the level of DAT is elevated on the cellular membrane. Interestingly, there were no statistically significant changes in the extracellular or tissue concentration of DA in the striatum, indicating that the physiological amount of PREP in DAergic neurons is sufficient to regulate DAT trafficking effectively. However, PREP overexpression resulted in an increased level of the extracellular GABA and HVA in the striatum, and elevated tissue DA levels in the SN. Since this is the first time when PREP has been connected to the DAT functions and trafficking, the mechanism behind this is not yet known. PREP has been connected to cellular microtubule network, and trafficking and secretion of proteins [10] , which might link it to DAT trafficking and internalization. Other possibility is that PREP regulates the phosphorylation of DAT via PKC or Jun-kinases but both of these theories require further studies.
In addition, increased explorative behavior in locomotor activity test correlates with the elevated DAergic activity in the nigrostriatal tract of PREP-KO mice. Locomotor hyperactivity of the PREP-KO mice has also been found in an earlier study [33] and acute PREP inhibition has also resulted in increased explorative activity in rats [50] , suggesting a role of PREP in DA-regulated locomotor activity.
Restoring PREP function did not have an effect on the extracellular level of neurotransmitters and their metabolites or DA-related proteins indicating that the PREP-KO mice might have some compensating mechanisms regulating DAergic system. However, the tissue concentration of DA in the striatum was elevated which might indicate a normalized DA function and might explain the increased use of contralateral paw in the cylinder test. Intriguingly, AAV-GFP had a toxic effect on contralateral paw use in the Wt but not in PREP-KO mice in the cylinder test, suggesting that the PREP-KO mice might have some neuroprotective mechanisms against the protein overexpression. One possible mechanism for this could be increased clearance of protein overload by cellular autophagy, as it has been shown PREP to be a negative regulator of PI3K class III autophagy [14] .
PREP inhibition has been shown to increase the striatal tissue concentration of DA in aged A30P point-mutated transgenic mice but not in Wt mice [14] and to reduce extracellular DA after acute dosing in rats [15] . In this study, we found that the 5-day treatment with PREP inhibitor did not have an effect on the extracellular concentration of DA in either genotype but the level of DA metabolites was increased in the Wt mice. Tissue concentration of DA and 5-HT, their metabolites, GABA, glutamate, or DAT was not changed. In the previous study [14] , the level of DA metabolites was increased in the striatal tissue. However, in that study, the samples were collected 32 h after the last injection of KYP-2047 whereas in this study, the tissue samples were collected already 8 h after the injections. The different time point might explain the difference in the results. Additionally, we used young mice in this study whereas mice aged 12 to 16 months were used in the previous study. In the earlier study, DAT immunoreactivity in striatum was increased after the chronic PREP inhibition but we did not find any differences in the DAT in a Western blot analysis despite that the PREP overexpression-induced the striatal DAT level. However, aging may cause the alteration in DAT function, which might explain the difference between young mice in this study and aged mice in the previous study [51] [52] [53] . Furthermore, we did not use long-term inhibition of PREP in the present study. In contrast to the study by Jalkanen et al. [15] , we did not find any changes in DA or metabolite levels following an acute PREP inhibitor injection but the dissimilarity may be explained by a different dose of KYP-2047 (5 vs. 17 mg/kg) and by the use of different species.
In conclusion, our results show that (1) the absence and the overexpression of PREP causes changes in phosphorylation of DAT, (2) the active site inhibitor KYP-2047 does not imitate the lack of PREP expression, (3) the hyperactivity of PREP-KO mice is due to increased DA action, and (4) the restoration of PREP function does not have effect on DAT indicating compensative mechanisms in PREP-KO mice. The results suggest that PREP protein has a remarkable role in the nigrostriatal DAergic system by regulating DAT trafficking or internalization.
